Course Materials (Online Syllabus)

Below you will find the educational information presented during the IDEAL® CME/CE activity at AAFP, held on Ocotber 22-25, 2014 in Washington, DC – The Diabetes Duet: Developing a Collaborative Care Plan in Concert with Your Patient to Reduce Risk and Improve Outcomes. This material is provided for your information only. CME/CE credit was offered for participating during the live event only.

To download a PDF copy of the panels and transcripts, click here
To download a PDF copy of the clinical pearl handouts, click here

PROGRAM PANELS
Panel 1: HITTING THE RIGHT NOTE: RISK FACTORS ASSOCIATED WITH EARLY IDENTIFICATION OF PRE-DIABETIC AND DIABETIC PATIENTS
References can be found on the
Resources page
Panel 1: HITTING THE RIGHT NOTE: RISK FACTORS ASSOCIATED WITH EARLY IDENTIFICATION OF PRE-DIABETIC AND DIABETIC PATIENTS
All of the following are correct regarding the difficulty in managing diabetes, except:
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 2: IT TAKES TWO TO TANGO: THE ROLE OF MOTIVATIONAL INTERVIEWING IN DEVELOPMENT OF SUCCESSFUL DIABETES MANAGEMENT PLANS
References can be found on the
Resources page
Panel 2: IT TAKES TWO TO TANGO: THE ROLE OF MOTIVATIONAL INTERVIEWING IN DEVELOPMENT OF SUCCESSFUL DIABETES MANAGEMENT PLANS
All of the following are correct about motivational interviewing, except:
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 3: CHANGE YOUR TUNE: CHANGING PRECONCEPTION ABOUT DIABETES AND DIABETES COMORBIDITIES
References can be found on the
Resources page
Panel 3: CHANGE YOUR TUNE: CHANGING PRECONCEPTION ABOUT DIABETES AND DIABETES COMORBIDITIES
True or False, pre-diabetic and diabetic patients should limit their physical activity in order to avoid aggravating any pre-existing comorbidities.
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 4: PULL OUT ALL THE STOPS: GLYCEMIC CONTROL, MONITORING AND MANAGEMENT GOALS
References can be found on the
Resources page
Panel 4: PULL OUT ALL THE STOPS: GLYCEMIC CONTROL, MONITORING AND MANAGEMENT GOALS
True or False, targeting A1C of approximately 6.5% is essential for all diabetes patients as part of their management plan?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 5: STRIKE A CHORD: FINDING THE APPROPRIATE THERAPEUTIC APPROACH FOR YOUR PATIENT, EARLY INTERVENTION STRATEGIES
References can be found on the
Resources page
Panel 5: STRIKE A CHORD: FINDING THE APPROPRIATE THERAPEUTIC APPROACH FOR YOUR PATIENT, EARLY INTERVENTION STRATEGIES
True or False, per the American Diabetes Association and American Association of Clinical Endocrinologist guidelines, intensive glucose control, including the use of insulin, is essential in treatment of pre-diabetic patients.
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 6: FINE TUNING A1C < 7.5%: ADJUSTING DIABETES THERAPY BASED ON YOUR PATIENT\S NEEDS
References can be found on the
Resources page
Panel 6: FINE TUNING A1C < 7.5%: ADJUSTING DIABETES THERAPY BASED ON YOUR PATIENT\S NEEDS
Which of the following are essential for establishing a successful diabetes management plan?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 7: FINE TUNING A1C > 7.5%: ADJUSTING DIABETES THERAPY BASED ON YOUR PATIENT\'S NEEDS
References can be found on the
Resources page
Panel 7: FINE TUNING A1C > 7.5%: ADJUSTING DIABETES THERAPY BASED ON YOUR PATIENT\'S NEEDS
What needs to be considered when choosing a glycemic therapy for you diabetic patient?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---

SPONSORSHIP
Supported in part by a grant to the AAFP from Merck and Novo Nordisk.
IDEAL® technology for this activity is provided by Educational Awareness Solutions.